Added to YB: 2025-08-07
Pitch date: 2025-06-20
MDXH [bullish]
MDxHealth SA
+84.69%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.
Market Cap
$174.6M
Pitch Price
$1.96
Price Target
8.00 (+121%)
Dividend
N/A
EV/EBITDA
-41.56
P/E
-5.32
EV/Sales
2.24
Sector
Biotechnology
Category
growth
Show full summary:
MDxHealth SA - $MDXH
MDXH: Commercial-stage molecular diagnostics company w/ 16 consecutive quarters of 20%+ growth. Targeting AEBITDA breakeven 2Q25. Trades at just 1.3x sales despite 20-22% organic growth forecast. Strong mgmt executing Stryker-style channel strategy in urology. Debt/earnout concerns priced in. PT $8 (3x sales) within 18mo.
Read full article (9 min)